Our work culture integrates ethics transparency, risk and compliance processes


At Abdi İbrahim, we are one ambitious family chasing big goals and big ideals, determined to give back to our native country through investment, production, export and employment. We are carrying our journey of “healing”, which began in 1912 and accumulated a long-established corporate culture, into the future, now with growing value in the international markets.

TL 63 million

R&D spending


Operations in +60 countries

TL 712 million



seamless market leadership 

200 Brands

Broadest brand portfolio in the industry

400 products

Broadest product portfolio in the industry

*Data from 2020.


Achieve our goals with a culture that integrates the ethics, transparency, risk and compliance processes we have adopted.


Develop new products to keep bettering lives

Develop our proprietary biotech pharmaceuticals

Become a permanent actor in developed markets

Further expand across international markets and raise our overseas revenue share in total

Make Turkey a major manufacturing base in Europe for production services.

Remain a profitable business and the market leader in Turkey

Rank among the 10 most reputable enterprises with a strong brand name, and a high employee value proposition.

Make the integrated corporate culture sustainable in ethics, transparency, risk and compliance processes.

At Abdi İbrahim, we embrace a future-facing mindset through our visionary perspective and innovative management approach with a view to further improving our competencies that are prerequisites for our sustainable success and strive to become a key global player with long-term planning and strategies.

DR. Süha Taşpolatoğlu

CEO, Abdi İbrahim

Sustainable Development Goals that we support through managerial steps


Revenue (in million TL)
Exports (in million TL)
R&D Spending (in million TL)
R&D Employees
Patents / Patented Products
Products Recalled


Abdi İbrahim Code of Ethics, the core of our signature values and principles, reflects our commitment and dedication to the core tenets of business and ethics within the context of our corporate responsibilities towards all stakeholders.


We continue on our journey of “healing”, which began in 1912, fully aware that human health is our primary responsibility. Guided by this understanding, we believe in the importance of doing our job with great care, attention and integrity, and always maintaining the highest standards accordingly. Because we believe that, as a company, the way we achieve success is as important as the accomplishment itself.

With this belief, we have recorded our code of ethics, which have always served as an essential guide for us, in order to carry our stakeholders’ trust in and respect for us into the future. We then announced our code of ethics to our employees on December 30, 2015, and to external stakeholders on February 10, 2016. We consider one of our most critical responsibilities is commitment to these guidelines across all the work processes. The Ethics Board established within our company is set to assist our stakeholders with respect to all future content.

We attach great importance to working with the principles of ethics and transparency in all our business processes. We produce and deliver all of our products with the highest technology and in line with all quality and safety conditions required by all legal regulations, particularly international standards and intellectual rights. We consider product safety one of our indispensable principles. In this scope, our company’s pharmacovigilance system and cGMP-approved production facilities audited by national and international health authorities and companies have successfully underwent all audits carried out in 2019-2020.

Adi İbrahim Staff Regulations lay down the following obligations for the employees:

  • Obligation to work efficiently and meticulously
  • Obligation to protect company’s interests
  • Confidentiality obligation
  • Obligation to obey the law

Code of Ethics

  • Impartiality
  • Integrity
  • Reliability
  • Transparency
  • Social good and respect for the environment
  • Information security

Click here to see our Business Ethics Principles.

Business Ethics Reporting Hotline

Internal and external stakeholders can report to the Ethics Hotline any issue they consider to be contradicting Abdi İbrahim’s Business Ethics Principles. Each report is addressed and assessed against the Business Ethics Principles, and then submitted to the Ethics Board.
Complaints can be made to the Ethics Board via e-mail, mail, or phone. Suppliers, physicians, pharmacists and patients can report to etikhat@abdiibrahim.com.tr or the phone numbers available on our website. Ethics Hotline receives an average 30 reports in a year.

Click here for your reports, questions and comments about our ethics principles.


Our in-house Internal Audit Department, an independent and impartial entity, oversees all the operations of Abdi İbrahim in terms of effectiveness, efficiency, and compliance with laws, policies, regulations and procedures and reports to the Board of Directors.


Launched in 2006 within Abdi İbrahim, the Internal Audit Department’s activities are governed by the Audit Committee Regulations and Internal Audit Regulations that took effect upon the Board decision of March 2013. Our team focuses on adding value to the risk management, control and governance processes via risk-based auditing.

Internal and external controls, early warning mechanisms and audits are strategic instruments in our Company’s fight against corruption and bribery. We audit the activities of our employees, customers and their subcontractors on a regular basis. Our primary endeavour is to make sure all stakeholders adopt and internalize the principles and ethical values as required. Our corporate values in that respect encompass the following principles:

  • Valuing people
  • Reliability
  • Entrepreneurship and innovation
  • Focus on quality
  • Customer-oriented
  • Dedicated to success
  • Respect for the environment


With a total of 5,000 local and international partners in our supply chain, we forge relationships grounded in ethical values such as integrity, fairness, transparency, and truthfulness. We prefer companies with which we can have a long-lasting collaboration; we pay utmost attention to compliance with occupational health & safety regulations and ethical guidelines.


At Abdi İbrahim, we conduct procurement activities in three main areas: direct material, indirect material, and investment. We plan these procurements, which total approximately 30,000 orders per year, in parallel with our long-term and short-term corporate policies. Supplier selection and improvement of business processes are among the company’s top priorities in its procurement processes. We choose to work with companies with whom we can develop long-term and sustainable collaborations and pay utmost attention to the compliance of our suppliers to legal regulations and ethical rules in the area of occupational health and safety. We also carry out activities to increase the capacity of our suppliers in the area of sustainability.

We bolster supplier contracts with the guidance of the Turkish Labor Law no. 4857 in the control and procedural processes. We engage in improvement and development work with our suppliers in a bid to mutually enhance business processes and construct a sustainable procurement and supply chain.


Since inception, we have been thriving on a solid R&D culture and utilizing science to develop quality and affordable solutions for human health. We therefore take R&D, that is the key to progress and innovation, very seriously.


Being the first accredited pharmaceutical R&D Centre in Turkey, we provide state-of-the-art services at our latest formulation and analytical method development labs. We have the capability and infrastructure to develop pharmaceuticals through inhalation technology and nanotechnology to meet the ever-changing and progressive needs of the national and international pharma industries.

With a team of 133, our R&D Centre focuses on developing innovative and added value products, achieving high success rate in bioequivalence studies, accelerating the processes for signature product development and preparing Common Technical Document (CTD) files for Turkey, Europe and other markets. We conduct joint projects with local and global scientific institutions and transfer know-how.

Intellectual and Industrial Property Rights

Leading the Turkish pharmaceutical market in R&D funds, our Company has, as of the end of 2020, filed 174 patent applications in Turkey, Europe and globally, with 41 approved patents in Turkey and Europe combined.


We are aware that human health depends on planetary health. By joining world-renowned sustainability initiatives, we closely follow the international standards and remain a part of the solution for a good future.


United Nations Global Compact

We have signed and joined the United Nations Global Compact (UNGC). We focus on integrating the 10 UN Global Compact principles, which serve as the framework for 17 priority sustainable development goals, into all of our business processes, strategies and operations; every year, we present our Progress Report to our stakeholders.


Global Reporting Initiative

In another indicator of our commitment to fostering sustainability as a broader and systematic effort, since 2013 we have been producing and publishing, biennial sustainability reports based on the Global Reporting Initiative (GRI) criteria.


Women’s Empowerment Principles

As an ardent supporter of women and women’s employment, we have signed Women’s Empowerment Principles (WEPs), a UN initiative for the private sector, that seeks to empower women to help them be active in the economic life, at every level of every industry.


Business Council for Sustainable Development Turkey

We have joined the Business Council for Sustainable Development Turkey (BCSD Turkey), the local network and partner of the World Business Council for Sustainable Development (WBCSD).

Carbon Disclosure Project

We have become a member of one of the biggest non-governmental authorities in sustainability, Carbon Disclosure Project (CDP).
This platform has the most extensive environmental database in the world.


CEO Water Mandate

We have become a signatory party to CEO Water Mandate, a UN Global Compact initiative. We were the first Turkish pharma company to have joined this platform.

Science Based Targets Initiative

As well as being the first signatory to the Science Based Targets Initiative (SBTi) in the Turkish pharmaceutical industry, we have become one of the eight pioneers with a science-based commitment to reducing emissions in production.

Recover Better

We have signed the Recover Better statement; a joint commitment launched by the United Nations and the Science Based Targets Initiative in an attempt to sustain nature’s recovery triggered by pandemic-related human immobility, with the support of companies and institutions; to become the first and only signatory party from Turkey.

The Business Plastic Initiative (İş Dünyası Plastik Girişimi)

We are a signatory party to the Business Plastic Initiative that was founded by Global Compact Turkey, Business Council for Sustainable Development Turkey (BCSD Turkey) and Turkish Industry and Business Association (TÜSİAD) with the aim of tackling plastic pollution.

Turkey's Circular Economy Platform

We have become a member of the Turkey's Circular Economy Platform built by BCSD Turkey and The European Bank for Reconstruction and Development (EBRD) in order to raise awareness on the circular economy and accelerate the transition to the new era.

Turkey Materials Marketplace

We have joined Turkey Materials Marketplace (TMM) that was launched by the BCSD Turkey-EBRD initiative Turkey's Circular Economy Platform in an endeavour to fulfil the need for information/resources on the circular economy, introduce measurement techniques, offer technical grants and create partnership opportunities.



Our sustainability efforts, which account for our corporate strategic priorities, are monitored at the Board level. Our Sustainability Committee, comprised of 40 volunteers led by our CEO, assembles biannually to assess our performance against targets and reviews our sustainability efforts.

Your feedback matters to us

We welcome your comments and suggestions on our corporate sustainability efforts.
To give feedback and learn more, please contact our Sustainability Committee.